Daewoong seeking to clarify controversial efficacy of Ursa
Published: 2013-09-11 06:59:00
Updated: 2013-09-11 06:59:00
Daewoong Pharm is making all-out to publicize more correct information of Ursa (ursodeoxycholic acid; UCDA) to the public, while dispelling the local media’s recent report that Ursa is a simple digestive, being far from a liver protectant.
Company official said that Ursa is indicated for impro...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
